F-star and Christian Doppler Lab in new collaboration

UK-based biotech F-star has announced the extension of a collaboration and funding arrangement with the Christian Doppler (CD) Laboratory for Innovative Immunotherapeutics at the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria.

F-star, which has partnered with some of pharma’s leading companies, sees the collaboration as key to strengthening its position in immuno-oncology and bispecific antibodies by allowing the company to explore additional applications of its powerful Modular Antibody Technology.

The Cambridge-based company will retain rights to intellectual property arising from work in the lab. It has hailed the collaboration as a great example of UK biopharma leveraging public-private partnerships and build strong academic bridges globally, including in Europe, to drive cutting edge innovation.